Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment–elevation myocardial infarction during the COVID-19 pandemic—The experience from the largest cardiovascular-specific centre in China

BACKGROUND: The impact of fibrinolysis-first strategy on outcomes of patients with ST-segment-elevation myocardial infarction (STEMI) during the COVID-19 pandemic was unknown. METHODS: Data from STEMI patients presenting to Fuwai Hospital from January 23 to April 30, 2020 were compared with those du...

Descripción completa

Detalles Bibliográficos
Autores principales: Leng, Wen-Xiu, Yang, Jin-Gang, Li, Xiang-Dong, Jiang, Wen-Yang, Gao, Li-Jian, Wu, Yuan, Yang, Yan-Min, Yuan, Jin-Qing, Yang, Wei-Xian, Qiao, Shu-Bin, Yang, Yue-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723441/
https://www.ncbi.nlm.nih.gov/pubmed/33307137
http://dx.doi.org/10.1016/j.ijcard.2020.11.074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723441/
https://www.ncbi.nlm.nih.gov/pubmed/33307137
http://dx.doi.org/10.1016/j.ijcard.2020.11.074

Ejemplares similares